5 hasil untuk "Linwei Wu"
Menampilkan 1–5 · 0,34 detik · RSS
-
Artikel Jurnal Teks lengkap
Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
Objective: To summarize the experience with salvage liver transplantation (SLT) for patients with recurrent hepatocellular carcinoma (HCC) after primary hepatic resection in a single center. Methods: A total of 376 adult patients with HCC underwent orthotopic liver transplantation (OLT) at Organ…
-
Artikel Jurnal Teks lengkap
Down-Regulation of microRNA-26a Promotes Mouse Hepatocyte Proliferation during Liver Regeneration
Background: Inadequate liver regeneration (LR) is still an unsolved problem in major liver resection and small-for-size syndrome post-living donor liver transplantation. A number of microRNAs have been shown to play important roles in cell proliferation. Herein, we investigated the role of miR-26a…
-
Artikel Jurnal Teks lengkap
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
Background & Aims: Application of nucleoside analogues and hepatitis B immunoglobulin (HBIG) has reduced hepatitis B virus (HBV) recurrence rate after liver transplantation (LT) dramatically. Recent data suggests therapy without HBIG is also effective. We sought to evaluate the necessity of HBIG in…
-
Artikel Jurnal Teks lengkap
Machine Perfusion versus Cold Storage of Kidneys Derived from Donation after Cardiac Death: A Meta-Analysis
Background: In response to the increased organ shortage, organs derived from donation after cardiac death (DCD) donors are becoming an acceptable option once again for clinical use in transplantation. However, transplant outcomes in cases where DCD organs are used are not as favorable as those from…
-
Artikel Jurnal Teks lengkap
Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study
Introduction: Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NAs) is the standard treatment for controlling hepatitis B virus (HBV) recurrence after liver transplantation (LT). Since lifelong use of HBIG is expensive and inconvenient and the antibodies…